Literature DB >> 6105529

Value of stool cultures.

J P Koplan, H V Fineberg, M J Ferraro, M L Rosenberg.   

Abstract

An evaluation of stool cultures in a large teaching hospital where this test had been requested for 2468 patients in 1977 showed that only 58 patients (2.4%) had positive stool cultures (Salmonella or Shigella). Likelihood ratios computed from data from the medical records of 54 patients with positive stool cultures and a control group of 189 patients with negative cultures suggested that the best clinical predictor of a positive stool culture was the combination of persistent diarrhoea (duration more than 24 h), fever, and either blood in the stool or abdominal pain with nausea or vomiting. These findings were present in 20 of 52 patients with positive cultures, but in no patients with negative cultures. 53 patients had a positive result on the first culture done; 1 patient required 2 cultures. Microscopic examination for faecal leucocytes was not a useful predictor. In only 10 of 227 patients did culture results (positive or negative) lead to appropriate changes in treatment. The requirement that request forms be signed by a doctor, the limitation to no more than 2 stool cultures per illness, and consideration of the clinical predictors and their likelihood ratios for positive stool cultures would promote a more discerning use of this low-cost but low-yield diagnostic test.

Entities:  

Mesh:

Year:  1980        PMID: 6105529     DOI: 10.1016/s0140-6736(80)90453-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

1.  Simultaneous detection of six diarrhea-causing bacterial pathogens with an in-house PCR-luminex assay.

Authors:  Jie Liu; Jean Gratz; Athanasia Maro; Happy Kumburu; Gibson Kibiki; Mami Taniuchi; Arif Mahmud Howlader; Shihab U Sobuz; Rashidul Haque; Kaisar A Talukder; Shahida Qureshi; Anita Zaidi; Doris M Haverstick; Eric R Houpt
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Value of routine stool cultures in hospitalized patients with diarrhea.

Authors:  F Barbut; P Leluan; G Antoniotti; A Collignon; A Sédallian; J C Petit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

3.  Cost and time savings following introduction of rejection criteria for clinical specimens.

Authors:  A J Morris; L K Smith; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

4.  Rationale of using multiplex polymerase chain reaction (PCR) panels for etiological diagnosis of infective diarrhea in the tropics.

Authors:  Ujjala Ghoshal; Nidhi Tejan
Journal:  Indian J Gastroenterol       Date:  2018-09

Review 5.  Diagnostic deoxyribonucleic acid probes for infectious diseases.

Authors:  F C Tenover
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 6.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

7.  Role of stool screening tests in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens.

Authors:  R P Silletti; G Lee; E Ailey
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

8.  Measurement of fecal lactoferrin as a marker of fecal leukocytes.

Authors:  R L Guerrant; V Araujo; E Soares; K Kotloff; A A Lima; W H Cooper; A G Lee
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

9.  To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea.

Authors:  S W Choi; C H Park; T M Silva; E I Zaenker; R L Guerrant
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

10.  Etiology of Diarrhea, Nutritional Outcomes, and Novel Intestinal Biomarkers in Tanzanian Infants.

Authors:  Kerri B Gosselin; Said Aboud; Christine M McDonald; Sabrina Moyo; Nasim Khavari; Karim Manji; Rodrick Kisenge; Wafaie Fawzi; Mark Kellogg; Hao Q Tran; Gibson Kibiki; Jean Gratz; Jie Liu; Andrew Gewirtz; Eric Houpt; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-01       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.